MGX
NASDAQ · Biotechnology
Metagenomi Therapeutics Inc
$1.23
-0.01 (-0.81%)
Performance
1D
—
1W
+0.00%
1M
-0.81%
3M
-3.15%
6M
-16.33%
1Y
-16.33%
YTD
-16.33%
Open$1.24
Previous Close$1.24
Day High$1.25
Day Low$1.23
52W High$3.95
52W Low$1.13
Volume—
Avg Volume139.1K
Market Cap46.47M
P/E Ratio—
EPS$-2.30
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$1.24
Below
RSI (14)
40.6
Neutral
Analyst Ratings
Strong Buy
9 analysts
Price Target
+2,387.8% upside
Current
$1.23
$1.23
Target
$30.60
$30.60
$21.05
$30.60 avg
$40.98
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 25.57M | 22.51M | 24.43M |
| Net Income | -89,108,642 | -70,602,850 | -7,358,364 |
| Profit Margin | -348.5% | -331.1% | -30.1% |
| EBITDA | -91,975,925 | -76,923,257 | -8,749,975 |
| Free Cash Flow | — | — | -5,557,893 |
| Rev Growth | +13.6% | +13.6% | -4.6% |
| Debt/Equity | — | — | 0.41 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |